Colorectal Cancer Has Unique Microbial Fingerprint, Reveal Researchers
Colorectal cancer, the fourth most common cancer in the UK and the second deadliest, has a distinct microbial fingerprint that can help doctors better understand its development, aggression, and treatment response. New research from the University of East Anglia challenges the notion that all cancers have a unique microbial fingerprint, instead revealing that colorectal cancer possesses a distinct microbial community. This breakthrough could lead to more precise diagnoses, improved cancer care, and the development of new treatment options.
Key Takeaways:
- Colorectal cancer has a unique microbial fingerprint, distinguishable from other cancer types.
- The study analyzed WGS data from over 9,000 cancer patients, challenging previous claims of a unique microbial signature in cancer.
- Certain bacteria were associated with poorer survival rates in sarcoma cases, while the presence of specific bacteria linked to better survival rates in some cases.
- The study uncovered promising clinical applications, including the detection of viruses like HPV and rare but dangerous viruses like HTLV-1.
- The research highlights the potential of whole-genome sequencing in identifying pathogenic organisms, revealing hidden infections, and providing insight into cancer prognosis.
Statistics:
- 9,000+ cancer patients were included in the analysis of whole-genome sequencing (WGS) data.
- Colorectal cancer is the fourth most common cancer in the UK and the second deadliest.
- The study found that certain viruses, like HPV, were detected accurately in oral cancers compared to current medical tests.
- The presence of specific bacteria was associated with better survival rates in some sarcoma cases.
- The research was led by the University of East Anglia, in collaboration with 11 other institutions, including the University of Leeds, the Quadram Institute, and the University of Manchester.
Sources:
- "DNA analysis shows colorectal cancer has unique microbial fingerprint"
- University of East Anglia
- Genomics England
- Science Translational Medicine (publications)
- "Microbial Clues in Cancer: New Study Challenges Old Assumptions and Reveals Clinical Potential"